Search research articles
Contact Us
Filters
Showing results (161-170 of 496) with videos related to
Page
of 50
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 28, 2001
Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT(1D) receptors
V Audinot, A Newman-Tancredi, D Cussac, et al.
Neuropharmacology
|
May 30, 2001
Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT
A Dekeyne, J M Rivet, A Gobert, et al.
Journal of Neurochemistry
|
March 22, 2001
Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats
M J Millan, F Lejeune, G De Nanteuil, et al.
Oncology
|
January 1, 1988
A phase II trial of a new combination chemotherapy (cisplatin, bleomycin, VP-16 and methylprednisolone) in advanced recurrent squamous cell carcinoma of the head and neck
A Senra Varela, J Millan Nuñez-Cortes, P Gallurt Moreira
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 14, 2014
Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment
Mark J Millan, Kevin Fone, Thomas Steckler, et al.
Neuropharmacology
|
July 29, 1998
The role of 5-HT1A autoreceptors and alpha1-adrenoceptors in the modulation of 5-HT release--III. Clozapine and the novel putative antipsychotic S 16924
H J Bengtsson, A Kullberg, M J Millan, et al.
European Journal of Pharmacology
|
October 25, 2001
Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation
A Newman-Tancredi, L Verrièle, M Touzard, et al.
Acta Leprologica
|
January 1, 1992
[Detecting and monitoring leprosy neuropathy: which test to chose?]
J Grimaud, L Blum, B Verchaud, et al.
Neuropharmacology
|
March 23, 2000
[(35)S]-GTPgammaS autoradiography reveals alpha(2) adrenoceptor-mediated G-protein activation in amygdala and lateral septum
A Newman-Tancredi, C Chaput, M Touzard, et al.
Acta Leprologica
|
September 15, 2000
[Randomized controlled trial of medical and medico-surgical treatment of Hansen's neuritis]
P Boucher, J Millan, M Parent, et al.
Page
of 50
Search research articles
Search
Showing results (161-170 of 496) with videos related to
Sort By:
Page
of 50
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 28, 2001
Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT(1D) receptors
V Audinot, A Newman-Tancredi, D Cussac, et al.
Neuropharmacology
|
May 30, 2001
Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT
A Dekeyne, J M Rivet, A Gobert, et al.
Journal of Neurochemistry
|
March 22, 2001
Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats
M J Millan, F Lejeune, G De Nanteuil, et al.
Oncology
|
January 1, 1988
A phase II trial of a new combination chemotherapy (cisplatin, bleomycin, VP-16 and methylprednisolone) in advanced recurrent squamous cell carcinoma of the head and neck
A Senra Varela, J Millan Nuñez-Cortes, P Gallurt Moreira
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 14, 2014
Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment
Mark J Millan, Kevin Fone, Thomas Steckler, et al.
Neuropharmacology
|
July 29, 1998
The role of 5-HT1A autoreceptors and alpha1-adrenoceptors in the modulation of 5-HT release--III. Clozapine and the novel putative antipsychotic S 16924
H J Bengtsson, A Kullberg, M J Millan, et al.
European Journal of Pharmacology
|
October 25, 2001
Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation
A Newman-Tancredi, L Verrièle, M Touzard, et al.
Acta Leprologica
|
January 1, 1992
[Detecting and monitoring leprosy neuropathy: which test to chose?]
J Grimaud, L Blum, B Verchaud, et al.
Neuropharmacology
|
March 23, 2000
[(35)S]-GTPgammaS autoradiography reveals alpha(2) adrenoceptor-mediated G-protein activation in amygdala and lateral septum
A Newman-Tancredi, C Chaput, M Touzard, et al.
Acta Leprologica
|
September 15, 2000
[Randomized controlled trial of medical and medico-surgical treatment of Hansen's neuritis]
P Boucher, J Millan, M Parent, et al.
Page
of 50